Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Addendum richtlijn ‘Ziektemodulerende behandeling van Multiple Sclerose bij volwassenen’
nov 2020 | Multipele Sclerose